Sign in

CIK 0001671502 · Non-accelerated filer<br>Smaller reporting company

Quoin Pharmaceuticals Ltd.

Sign in to watch
Ticker
QNRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Incorporated
Israel
Entity type
operating
Phone
703 980 4182
Business address
42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349
Former names
Quoin Pharmaceuticals, Ltd., Cellect Biotechnology Ltd., Cellect Biomed Ltd.
Open-market buys, last 90 days
$279,966
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$279,966. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Carter Denise P. +$100K Chief Operating Officer 1 filing
  2. Myers Michael +$100K Chief Executive Officer 1 filing
  3. Lawlor Sally Bridget +$50K Chief Financial Officer 1 filing
  4. Culverwell Anthony James +$30K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2025-10-14 LANGER DENNIS Director Purchase · Series H Warrants (Right to Buy) +15,152 15,152
2025-10-14 LANGER DENNIS Director Purchase · Series I Warrants (Right to Buy) +15,152 15,152
2025-10-14 LANGER DENNIS Director Purchase · Series J Warrants (Right to Buy) +15,152 15,152
2025-10-14 LANGER DENNIS Director Purchase · Series K Warrants (Right to Buy) +15,152 15,152
2025-08-21 Leong Natalie Ee Mun Director Grant or award · Share Option (Right to Buy) +4,105 4,105
2025-08-21 Culverwell Anthony James Director Grant or award · Share Option (Right to Buy) +13,682 13,682
2025-08-21 LANGER DENNIS Director Grant or award · Share Option (Right to Buy) +13,682 13,682
2025-05-29 Carter Denise P. Chief Operating Officer Grant or award · Share Option (Right to Buy) +42,857 42,857
2025-05-29 Myers Michael Chief Executive Officer Grant or award · Share Option (Right to Buy) +42,857 42,857
2025-05-29 Culverwell Anthony James Director Grant or award · Share Option (Right to Buy) +7,760 7,760
2025-05-29 Myers Michael Chief Executive Officer Grant or award · Share Option (Right to Buy) +42,039 42,039
2025-05-29 Carter Denise P. Chief Operating Officer Grant or award · Share Option (Right to Buy) +42,039 42,039
2025-05-29 Leong Natalie Ee Mun Director Grant or award · Share Option (Right to Buy) +7,760 7,760
2025-05-29 LANGER DENNIS Director Grant or award · Share Option (Right to Buy) +7,760 7,760
2025-05-29 Cooper Joseph Patrick Director Grant or award · Share Option (Right to Buy) +7,760 7,760
2025-05-29 SEMBER MICHAEL T Director Grant or award · Share Option (Right to Buy) +7,760 7,760
2024-12-23 Carter Denise P. Chief Operating Officer Purchase +555,556 $0.45 $250K 602,648
2024-12-23 Carter Denise P. Chief Operating Officer Purchase · Series F Warrants (right to buy) +555,556 555,556
2024-12-23 Carter Denise P. Chief Operating Officer Purchase · Series G Warrants (right to buy) +555,556 555,556
2024-12-23 Myers Michael Chief Executive Officer Purchase +555,556 $0.45 $250K 602,808

Page 2 of 4 · 78 trades